Table: begin end state 1 27 cytoplasmic 28 51 transmembrane 52 64 non-cytoplasmic 65 84 transmembrane 85 95 cytoplasmic 96 115 transmembrane 116 120 non-cytoplasmic 121 143 transmembrane 144 154 cytoplasmic 155 178 transmembrane 179 183 non-cytoplasmic 184 205 transmembrane 206 262 cytoplasmic 263 282 transmembrane 283 293 non-cytoplasmic 294 317 transmembrane 318 326 cytoplasmic 327 347 transmembrane 348 352 non-cytoplasmic 353 376 transmembrane 377 387 cytoplasmic 388 412 transmembrane 413 417 non-cytoplasmic 418 438 transmembrane 439 447 cytoplasmic
Input: >HSERO_RS05600 MSIHTSGALPTVHVDQVVEQGRFGAFQFGLLLLCGLCLIIDGFDVQAMGYVAPAIIADWG VSKASLGPVFGAGLFGMLLGSLVLTPVGDRYGRRPVLILSTLFFALCMLATPMVTTLDQL LVLRFITGFGLGSIMPNAMALVGEFSPSSSRVTRMMLVSCGFTVGAAAGGFVSAALIPAY GWHAVFWVGGAVPLVLGLAMLVWLPESIQFLVLHRRPRTQVARWLRKLDPNIVIDDKTEV VVKETKAEGMPVAALFRDGRAGVTVLLWLISFMNLINLYFLSNWLPTLIRDAGYSTSMAV LIGTSLQVGGVIGTLSLGRFIQRFGFTRVLGSCFLLACLSIALIGKLATVPALLFVAVIV AGFCIVGGQPAVNALAGTFYPTTLRSTGIGWALGIGRIGSVVGPVIGGQLIALQWTNASL FLAAAVPALISALTIARLHRTAQGVSA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server